The only published study on the subject, evaluating VDR variants in 29 patients with familial MS and comparing them to unrelated controls, found a significant difference between groups for the TaqI variant of VDR (Yucel et al., 2018). The gene discussed is VDR; the disease is myeloid sarcoma.